Drug · CHEMBL871
ETIDRONIC ACID
7 sourcespipelines-2026-09-18-0.3.1
Cite this record
ConductScience Library. ETIDRONIC ACID. Drugs and targets, record CHEMBL871. Release pipelines-2026-09-18-0.3.1, 18 Sept 2026. https://conductscience.org/library/drugs/CHEMBL871
On this page
Drug
Names and IDs as ChEMBL gives them, through Open Targets.
Targets0
The targets ChEMBL's mechanism records give for the drug, through Open Targets. A mechanism record says what the drug acts on, not how strongly.
None in this release.
Diseases5
The diseases Open Targets' clinical reports study the drug for, the most trial reports first. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.
| Disease | Open Targets' stage | Stage reported by | Reports | Of them trials | Its drugs |
|---|---|---|---|---|---|
| Pain | Phase 2 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=HP_0012531 |
| bilateral striopallidodentate calcinosis | Phase 2 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=MONDO_0008947 |
| ischemia | Phase 2 | ClinicalTrials.gov | 1 | 1 | https://conductscience.org/library/drugs?q=EFO_0000556 |
| Paget disease | Approval | TTD | 1 | 0 | https://conductscience.org/library/drugs?q=MONDO_0021165 |
| bone disorder | Approval | ATC | 1 | 0 | https://conductscience.org/library/drugs?q=MONDO_0005381 |
Source Open Targets
Trials9
Trials whose record names the drug by a name ChEMBL states, posted results first, then the largest. Open Targets read each trial's text to find its drugs.
| Trial | Title | Phase | Participants | Results first posted | Named as | Linked by | Source |
|---|---|---|---|---|---|---|---|
| NCT01585402 | Etidronate for Arterial Calcifications Due to Deficiency in CD73 (ACDC) | Phase 2 | 7 | 2022-10-04 | etidronate | Its name | ClinicalTrials.gov |
| NCT01077817 | Observational Study of Incidence Rates of Esophageal Cancer in Women Taking Medications for the Prevention or Treatment of Osteoporosis (MK-0217A-352) | 684,815 | 2013-05-01 | etidronate | Its name | ClinicalTrials.gov | |
| NCT00376662 | HRT Versus Etidronate for Osteoporosis and Fractures in Asthmatics Receiving Glucocorticoids. | Phase 4 | 750 | etidronate | Its name | ClinicalTrials.gov | |
| NCT05778227 | Comparing Different Single and Combination Chelating Agents on Sealer Penetration and Dentin Erosion. | 100 | etidronic acid | Its name | ClinicalTrials.gov | ||
| NCT05662111 | Treatment of Ectopic Calcification in Fahr's Disease or Syndrome | Phase 2 | 98 | etidronate | Its name | ClinicalTrials.gov | |
| NCT05832580 | The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum | Phase 3 | 76 | etidronate | Its name | ClinicalTrials.gov | |
| NCT06597825 | Antibacterial Effect of NaOCl With Etidronic Acid in Apical Periodontitis Treatment | 40 | etidronic acid | Its name | ClinicalTrials.gov | ||
| NCT04035330 | Effect of Etidronate in Sodium Hypochlorite Versus Sodium Hypochlorite on the Intensity of Postoperative Pain | 34 | etidronate | Its name | ClinicalTrials.gov | ||
| NCT02673060 | A Trial of MBC-11 in Patients With CIBD | Phase 1 | 16 | etidronate | Its name | ClinicalTrials.gov |
Comparisons in its trials0
Comparisons Trial comparisons calculated in the trials whose record names the drug, most participants first. A comparison in one of its trials does not always compare the drug, so read the two groups.
None in this release.
Papers from its trials5
The papers the trials whose record names the drug list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.
Tests in its trials8
The tests ConductCognition runs that the trials whose record names the drug name in their registered outcomes, as ScienceGraph matched them. ConductCognition's list names the tests it runs, not every test a trial used.
| Test | Trials naming it as an outcome | As a primary outcome | Source |
|---|---|---|---|
| Category Fluency | 1 | 0 | ConductCognition |
| Complex Figure Copy and Recall | 1 | 1 | ConductCognition |
| Digit Span Test | 1 | 1 | ConductCognition |
| Rule Anticipation Test | 1 | 0 | ConductCognition |
| Stroop Color-Word Test | 1 | 0 | ConductCognition |
| Trail Making Test A | 1 | 1 | ConductCognition |
| Trail Making Test B | 1 | 1 | ConductCognition |
| Verbal Fluency | 1 | 1 | ConductCognition |
Data dates
The date of each source this release read.
Sources 7
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ConductCognition's list of its testsOur own data
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ConductCognition's list of its testsOur own data: ConductCognition's list of its tests, https://conductcognition.com
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this drug from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/drugs/v1/CHEMBL871
GET https://conductscience.org/api/drugs/v1/CHEMBL871/targets